Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism

Enrico Di Stasio, R. Cesareo, F. Vescini, G. Campagna, R. Cianni, V. Pasqualini, F. Grimaldi, S. Manfrini, A. Palermo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

29 Citazioni (Scopus)

Abstract

No data on the pharmacological treatment of normocalcemic hyperparathyroidism (NPHPT) are available. We treated 30 NPHPT postmenopausal women with alendronate/cholecalciferol (treated group) or vitamin D alone (control group). Over 1 year, bone mineral density (BMD) increased significantly in treated group, but not in control group. Both treatments did not affect serum or urinary calcium.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaOsteoporosis International
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Vitamin D

Fingerprint Entra nei temi di ricerca di 'Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism'. Insieme formano una fingerprint unica.

Cita questo